286(top 1%)
PR articles
25.1K(top 1%)
PR citations
88(top 0.1%)
PR h-index
99(top 0.1%)
h-index
455
documents
33.4K
doc citations
3.1K
citing journals
100
times ranked

Publications

286 peer-reviewed articles • 25,603 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Relapsing Anti-GAD65-Associated Encephalitis Responsive to Thymoma Resection, Radiation, and Immunomodulatory Therapy
Neurohospitalist, The, 2024, 14, 363-365
0.70Citations (PDF)
2A 79-Year-Old Woman With Worsening Headaches and Pachymeningeal Enhancement
Neurology: Neuroimmunology and NeuroInflammation, 2024, 11,
6.70Citations (PDF)
3The Historical Case for a Strong and Diverse Neurology Clerkship Leadership Team
Neurology: Education, 2024, 3,
0.93Citations (PDF)
4Sudden Sensorineural Hearing and Vestibular Loss in a Case of Relapsing Polychondritis
Annals of Otology, Rhinology and Laryngology, 2021, 130, 1412-1416
1.46Citations (PDF)
5Large Mitochondrial DNA Deletions in HIV Sensory Neuropathy
Neurology, 2021, 97,
1.08Citations (PDF)
6Neurosyphilis, MOGAD or both? A case of meningoencephalomyelitis associated with MOG-IgG seropositivity in a patient with syphilis
Neuroimmunology Reports, 2021, 1, 100003
0.44Citations (PDF)
7Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies
Current Opinion in Neurology, 2020, 33, 397-404
3.860Citations (PDF)
8Neurological manifestations associated with COVID-19: a review and a call for action
Journal of Neurology, 2020, 267, 1573-1576
3.4129Citations (PDF)
9Acute myocardial infarction associated with initial alemtuzumab infusion cycle in relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, 2019, 34, 100-102
2.27Citations (PDF)
10Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study
Lancet HIV,the, 2019, 6, e456-e462
7.921Citations (PDF)
11Solitary sclerosis presenting as isolated spontaneous paroxysmal dysarthria
ENeurologicalSci, 2019, 14, 98-100
1.17Citations (PDF)
12Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients
Neurology, 2019, 92,
1.014Citations (PDF)
13Brachial plexitis: an unusual presentation in sickle cell disease
Journal of Community Hospital Internal Medicine Perspectives, 2019, 9, 437-439
0.42Citations (PDF)
14Clinician-rated measures for distal symmetrical axonal polyneuropathy
Neurology, 2019, 93, 346-360
1.024Citations (PDF)
15Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice
Aids, 2019, 33, 973-984
2.551Citations (PDF)
16Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy
Aids, 2019, 33, S145-S157
2.5133Citations (PDF)
17Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus–Infected Patients
Journal of Acquired Immune Deficiency Syndromes (1999), 2019, 82, 61-70
1.828Citations (PDF)
18Advanced Pediatric Neurosonography Techniques: Contrast‐Enhanced Ultrasonography, Elastography, and Beyond
Journal of Neuroimaging, 2018, 28, 150-157
2.321Citations (PDF)
19Hemochromatosis ( HFE ) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy
AIDS Research and Human Retroviruses, 2018, 34, 942-949
1.46Citations (PDF)
20The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations
Journal of Pain, 2017, 18, 757-777
1.3134Citations (PDF)
21Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment
Journal of Neuroinflammation, 2017, 14,
9.032Citations (PDF)
22Treatment of human immunodeficiency virus-related peripheral neuropathy with Scrambler Therapy: a case report
International Journal of STD and AIDS, 2017, 28, 202-204
1.224Citations (PDF)
23Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial
Journal of NeuroVirology, 2017, 24, 16-27
1.643Citations (PDF)
24HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment
Nature Reviews Neurology, 2016, 12, 234-248
28.6907Citations (PDF)
25Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era
Journal of Infectious Diseases, 2016, 213, 1065-1073
3.738Citations (PDF)
26Serum Brain Derived Neurotrophic Factor (BDNF) in Patients with HIV Cognitive Impairment (P1.326)
Neurology, 2016, 86,
1.00Citations (PDF)
27Neuroinflammation and Virus Replication in the Spinal Cord of Simian Immunodeficiency Virus–Infected Macaques
Journal of Neuropathology and Experimental Neurology, 2015, 74, 38-47
1.821Citations (PDF)
28Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people
Neurology, 2015, 84, 241-250
1.041Citations (PDF)
29Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients
Aids, 2015, 29, 559-569
2.569Citations (PDF)
30Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy
Journal of NeuroVirology, 2015, 21, 525-534
1.617Citations (PDF)
31CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease
Journal of NeuroVirology, 2015, 21, 559-567
1.638Citations (PDF)
32Cambinol, a Novel Inhibitor of Neutral Sphingomyelinase 2 Shows Neuroprotective Properties
PLoS ONE, 2015, 10, e0124481
2.395Citations (PDF)
33Genetic Variation in Iron Metabolism Is Associated with Neuropathic Pain and Pain Severity in HIV-Infected Patients on Antiretroviral Therapy
PLoS ONE, 2014, 9, e103123
2.331Citations (PDF)
34Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry
Journal of NeuroVirology, 2014, 20, 457-465
1.622Citations (PDF)
35The Armadillo as a Model for Peripheral Neuropathy in Leprosy
ILAR Journal, 2014, 54, 304-314
0.847Citations (PDF)
36Controversies in HIV-associated neurocognitive disorders
Lancet Neurology, The, 2014, 13, 1139-1151
17.9279Citations (PDF)
37Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
Neurology, 2014, 82, 2055-2062
1.0292Citations (PDF)
38Characterizing HIV Medication Adherence for Virologic Success Among Individuals Living With HIV/AIDS: Experience With the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Cohort
Journal of HIV/AIDS and Social Services, 2014, 13, 8-25
0.28Citations (PDF)
39Reply
Journal of Acquired Immune Deficiency Syndromes (1999), 2014, 65, e124-e125
1.80Citations (PDF)
40Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection
Journal of NeuroVirology, 2013, 19, 393-401
1.641Citations (PDF)
41Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders
Journal of NeuroVirology, 2013, 19, 82-88
1.665Citations (PDF)
42Brainstem encephalitis: etiologies, treatment, and predictors of outcome
Journal of Neurology, 2013, 260, 2312-2319
3.456Citations (PDF)
43A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder
Journal of NeuroVirology, 2013, 19, 432-441
1.619Citations (PDF)
44Emerging Infections of the Central Nervous System
Current Infectious Disease Reports, 2013, 15, 576-582
2.612Citations (PDF)
45Neurologic Complications and Considerations in HIV-Infected Persons
Current Infectious Disease Reports, 2013, 15, 61-66
2.616Citations (PDF)
46Older individuals with HIV infection have greater memory deficits than younger individuals
Journal of NeuroVirology, 2013, 19, 531-536
1.629Citations (PDF)
47Sleep, Function and HIV: A Multi-Method Assessment
AIDS and Behavior, 2013, 17, 2808-2815
1.969Citations (PDF)
48Anterior spinal artery syndrome presenting as cervical myelopathy in a patient with subclavian steal syndrome
Neurology: Clinical Practice, 2013, 3, 358-360
2.04Citations (PDF)
49Predictors of outcome in acute encephalitis
Neurology, 2013, 81, 793-800
1.0152Citations (PDF)
50A lipid storage–like disorder contributes to cognitive decline in HIV-infected subjects
Neurology, 2013, 81, 1492-1499
1.055Citations (PDF)
51Clinical Reasoning: Multiple cranial neuropathies in a young man
Neurology, 2013, 80,
1.04Citations (PDF)
52Protein-Free Efavirenz Concentrations in Cerebrospinal Fluid and Blood Plasma Are Equivalent: Applying the Law of Mass Action To Predict Protein-Free Drug Concentration
Antimicrobial Agents and Chemotherapy, 2013, 57, 1409-1414
4.148Citations (PDF)
53Ethnic differences in epidermal nerve fiber density
Muscle and Nerve, 2013, 48, 462-464
2.218Citations (PDF)
54Evaluating Sleep and Cognition in HIV
Journal of Acquired Immune Deficiency Syndromes (1999), 2013, 63, 609-616
1.857Citations (PDF)
55Fluctuations of Plasma Microbial Translocation Products among Patients at Risk of Chronic HIV-Associated Neurocognitive Disorder (P03.252)
Neurology, 2013, 80,
1.00Citations (PDF)
56Acute Encephalitis in the ICU: Predictors of Poor Outcome (P03.148)
Neurology, 2013, 80,
1.00Citations (PDF)
57The Evaluation and Diagnosis of "Insomnia" in Relation to Sleep Disturbance Prevalence and Impact in Early-Treated HIV-Infected Persons
Clinical Infectious Diseases, 2012, 55, 1429-1430
5.28Citations (PDF)
58Painful Small Fiber Neuropathies
CONTINUUM Lifelong Learning in Neurology, 2012, 18, 106-125
1.319Citations (PDF)
59Treatment of relapsing–remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance
Multiple Sclerosis Journal, 2012, 18, 202-209
3.926Citations (PDF)
60Peripheral Nerve Toxic Effects of Nitrofurantoin
Archives of Neurology, 2012, 69, 265
6.856Citations (PDF)
61The Sleep-Immunity Relationship
Neurologic Clinics, 2012, 30, 1313-1343
2.6116Citations (PDF)
62Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised
Neurology, 2012, 79, 2125-2132
1.0161Citations (PDF)
63HIV-associated opportunistic infections of the CNS
Lancet Neurology, The, 2012, 11, 605-617
17.9164Citations (PDF)
64A comparative evaluation of quantitative neuroimaging measurements of brain status in HIV infection
Psychiatry Research - Neuroimaging, 2012, 203, 95-99
1.917Citations (PDF)
65Health-Related Quality of Life ‘Well-Being' in HIV Distal Neuropathic Pain is More Strongly Associated with Depression Severity than with Pain Intensity
Psychosomatics, 2012, 53, 380-386
2.743Citations (PDF)
66Neurologic disorders incidence in HIV+ vs HIV− men
Neurology, 2012, 79, 1873-1880
1.068Citations (PDF)
67Dendritic Spine Injury Induced by the 8-Hydroxy Metabolite of Efavirenz
Journal of Pharmacology and Experimental Therapeutics, 2012, 343, 696-703
3.3132Citations (PDF)
68HIV-Associated Neurological Disorders
CNS Drugs, 2012, 26, 123-134
6.375Citations (PDF)
69SIV-induced impairment of neurovascular repair: a potential role for VEGF
Journal of NeuroVirology, 2012, 18, 222-230
1.613Citations (PDF)
70Needle type and the risk of post-lumbar puncture headache in the outpatient neurology clinic
Journal of the Neurological Sciences, 2011, 306, 24-28
2.150Citations (PDF)
71Macrophage-Mediated Dorsal Root Ganglion Damage Precedes Altered Nerve Conduction in SIV-Infected Macaques
American Journal of Pathology, 2011, 179, 2337-2345
3.451Citations (PDF)
72CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
Aids, 2011, 25, 1747-1751
2.5370Citations (PDF)
73Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy
Journal of Neuroimmunology, 2011, 238, 81-86
2.337Citations (PDF)
74Marked relationship between matrix metalloproteinase 7 and brain atrophy in HIV infection
Journal of NeuroVirology, 2011, 17, 153-158
1.614Citations (PDF)
75A comparison of performance-based measures of function in HIV-associated neurocognitive disorders
Journal of NeuroVirology, 2011, 17, 159-165
1.657Citations (PDF)
76Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy
Brain, 2011, 134, 1853-1863
8.485Citations (PDF)
77Peripheral neuropathy in HIV: prevalence and risk factors
Aids, 2011, 25, 919-928
2.5184Citations (PDF)
78Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 2011, 23, 921-928
1.447Citations (PDF)
79Immune reconstitution inflammatory syndrome in natalizumab-associated PML
Neurology, 2011, 77, 1061-1067
1.0227Citations (PDF)
80Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users
Neurology, 2011, 76, 787-794
1.027Citations (PDF)
81Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus
Journal of NeuroVirology, 2010, 16, 445-456
1.629Citations (PDF)
82Characterization of Nitrotyrosine-Modified Proteins in Cerebrospinal Fluid
Clinical Proteomics, 2010, 6, 29-41
2.86Citations (PDF)
83Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap
Annals of Neurology, 2010, 67, 699-714
6.6416Citations (PDF)
84Biomarkers of neurological status in HIV infection: A 3‐year study
Proteomics - Clinical Applications, 2010, 4, 295-303
2.224Citations (PDF)
85Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus–Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy
Archives of Neurology, 2010, 67, 552
6.8365Citations (PDF)
86Comparison of Scales to Evaluate the Progression of Hiv-Associated Neurocognitive Disorder
HIV Therapy, 2010, 4, 371-379
0.537Citations (PDF)
87Disturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virus
Journal of NeuroVirology, 2010, 16, 445-456
1.628Citations (PDF)
88Role of metabolic syndrome components in HIV-associated sensory neuropathy
Aids, 2009, 23, 2317-2322
2.528Citations (PDF)
89Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
Aids, 2009, 23, 1359-1366
2.5319Citations (PDF)
90PML-IRIS in patients with HIV infection
Neurology, 2009, 72, 1458-1464
1.0351Citations (PDF)
91Mirtazapine Use in Human Immunodeficiency Virus–Infected Patients With Progressive Multifocal Leukoencephalopathy
Archives of Neurology, 2009, 66,
6.8106Citations (PDF)
92Extensive astrocyte infection is prominent in human immunodeficiency virus–associated dementia
Annals of Neurology, 2009, 66, 253-258
6.6333Citations (PDF)
93Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model
Journal of Comparative Neurology, 2009, 514, 272-283
2.022Citations (PDF)
94Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection
Journal of NeuroVirology, 2009, 15, 275-281
1.625Citations (PDF)
95CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy
FASEB Journal, 2009, 23, 2928-2941
0.639Citations (PDF)
96Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
Archives of Neurology, 2008, 65, 65
6.8821Citations (PDF)
97Evolution of HIV dementia with HIV infection
International Review of Psychiatry, 2008, 20, 25-31
2.6115Citations (PDF)
98Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity
Neurology, 2008, 70, 1753-1762
1.030Citations (PDF)
99Cytokine Genotype Suggests a Role for Inflammation in Nucleoside Analog-Associated Sensory Neuropathy (NRTI-SN) and Predicts an Individual's NRTI-SN Risk
AIDS Research and Human Retroviruses, 2008, 24, 117-123
1.437Citations (PDF)
100Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS
Frontiers in Bioscience - Landmark, 2008, Volume, 5120
5.827Citations (PDF)
101Impaired reinnervation in HIV infection following experimental denervation
Neurology, 2007, 68, 1251-1256
1.044Citations (PDF)
102Associative and predictive biomarkers of dementia in HIV-1–infected patients
Neurology, 2007, 68, 1481-1487
1.0113Citations (PDF)
103An Evaluation of Neurocognitive Status and Markers of Immune Activation as Predictors of Time to Death in Advanced HIV Infection
Archives of Neurology, 2007, 64, 97
6.899Citations (PDF)
104Molecular programming of endothelin‐1 in HIV‐infected brain: role of Tat in up‐regulation of ET‐1 and its inhibition by statins
FASEB Journal, 2007, 21, 777-789
0.640Citations (PDF)
105Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies
Brain, 2007, 130, 2703-2714
8.4118Citations (PDF)
106Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa
Neurology, 2007, 68, 350-355
1.0119Citations (PDF)
107Platelet Decline
Archives of Neurology, 2007, 64, 1264
6.839Citations (PDF)
108The prevalence and incidence of neurocognitive impairment in the HAART era
Aids, 2007, 21, 1915-1921
2.5566Citations (PDF)
109Assessment of Epidermal Nerve Fibers
Journal of Neuropathology and Experimental Neurology, 2007, 66, 1059-073
1.8130Citations (PDF)
110AIDS dementia complex in China
Journal of Clinical Neuroscience, 2007, 14, 8-11
1.66Citations (PDF)
111Biomarkers of HIV-1 CNS infection and injury
Neurology, 2007, 69, 1781-1788
1.089Citations (PDF)
112A Randomized Trial Evaluating Prosaptide™ for HIV-Associated Sensory Neuropathies: Use of an Electronic Diary to Record Neuropathic Pain
PLoS ONE, 2007, 2, e551
2.342Citations (PDF)
113Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation
Journal of NeuroVirology, 2007, 13, 173-184
1.627Citations (PDF)
114The Role of Cohort Studies in Drug Development: Clinical Evidence of Antiviral Activity of Serotonin Reuptake Inhibitors and HMG-CoA Reductase Inhibitors in the Central Nervous System
Journal of NeuroImmune Pharmacology, 2007, 2, 120-127
2.942Citations (PDF)
115Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C–infected population in India
Journal of NeuroVirology, 2006, 12, 34-38
1.643Citations (PDF)
116Prevalence of human immunodeficiency virus–associated cognitive impairment in a group of Hispanic women at risk for neurological impairment
Journal of NeuroVirology, 2006, 12, 356-364
1.687Citations (PDF)
117NeuroAIDS, Drug Abuse, and Inflammation: Building Collaborative Research Activities
Journal of NeuroImmune Pharmacology, 2006, 1, 351-399
2.924Citations (PDF)
118Enzyme replacement therapy and intraepidermal innervation density in Fabry disease
Muscle and Nerve, 2006, 34, 53-56
2.284Citations (PDF)
119The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy
Neurology, 2006, 66, 256-258
1.0111Citations (PDF)
120Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients
Neurology, 2006, 67, 383-388
1.0179Citations (PDF)
121Factors influencing nerve regeneration in a trial of timcodar dimesylate
Neurology, 2006, 66, 259-261
1.033Citations (PDF)
122Later-Onset Fabry Disease
Archives of Neurology, 2006, 63, 453
6.856Citations (PDF)
123Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome
Nature Clinical Practice Neurology, 2006, 2, 557-565
6.079Citations (PDF)
124Is the Glass Three‐Quarters Full or One‐Quarter Empty?
Journal of Infectious Diseases, 2006, 194, 1628-1631
3.76Citations (PDF)
125Undetectable Cerebrospinal Fluid HIV RNA and β-2 Microglobulin Do Not Indicate Inactive AIDS Dementia Complex in Highly Active Antiretroviral Therapy-Treated Patients
Journal of Acquired Immune Deficiency Syndromes (1999), 2005, 39, 426-429
1.858Citations (PDF)
126Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS
Journal of NeuroVirology, 2005, 11, 346-355
1.6107Citations (PDF)
127Aquaporin 4 is increased in association with human immunodeficiency virus dementia: Implications for disease pathogenesis
Journal of NeuroVirology, 2005, 11, 535-543
1.641Citations (PDF)
128Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: The impact of gender and injection drug use
Journal of NeuroVirology, 2005, 11, 138-143
1.650Citations (PDF)
129Neurological complications of HIV infection
Lancet Neurology, The, 2005, 4, 543-555
17.9533Citations (PDF)
130Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation
Virology, 2005, 334, 178-193
2.364Citations (PDF)
131Markers of immune activation and viral load in HIV-associated sensory neuropathy
Neurology, 2005, 64, 842-848
1.081Citations (PDF)
132Evaluation of a clinical screening tool for HIV-associated sensory neuropathies
Neurology, 2005, 65, 1778-1781
1.0141Citations (PDF)
133A Programmable Prompting Device Improves Adherence to Highly Active Antiretroviral Therapy in HIV-Infected Subjects with Memory Impairment
Clinical Infectious Diseases, 2005, 41, 875-882
5.2113Citations (PDF)
134The reliability of skin biopsy with measurement of intraepidermal nerve fiber density
Journal of the Neurological Sciences, 2005, 228, 65-69
2.1128Citations (PDF)
135The Millennium Project: a plan for meeting the Millennium Development Goals
Lancet, The, 2005, 365, 347-353
62.1225Citations (PDF)
136A Randomized Controlled Trial of 5% Lidocaine Gel for HIV-Associated Distal Symmetric Polyneuropathy
Journal of Acquired Immune Deficiency Syndromes (1999), 2004, 37, 1584-1586
1.868Citations (PDF)
137The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy
Brain, 2004, 127, 1606-1615
8.4361Citations (PDF)
138Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies
Neurology, 2004, 62, 612-618
1.0102Citations (PDF)
139Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia
Neurology, 2004, 63, 626-630
1.067Citations (PDF)
140Amyloid precursor protein expression in circulating monocytes and brain macrophages from patients with HIV-associated cognitive impairment
Journal of Neuroimmunology, 2004, 157, 99-110
2.329Citations (PDF)
141HIV dementia: an evolving disease
Journal of Neuroimmunology, 2004, 157, 3-10
2.3403Citations (PDF)
142Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10
Virology, 2004, 329, 302-318
2.3172Citations (PDF)
143Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia
Annals of Neurology, 2004, 55, 257-267
6.6256Citations (PDF)
144HIV-associated neuromuscular weakness syndrome
Aids, 2004, 18, 1403-1412
2.555Citations (PDF)
145Attenuated Central Nervous System Infection in Advanced HIV/AIDS With Combination Antiretroviral Therapy
Archives of Neurology, 2004, 61, 1687
6.8127Citations (PDF)
146Human Immunodeficiency Virus-Associated Dementia: An Evolving Disease
Journal of NeuroVirology, 2003, 9, 205-221
1.6373Citations (PDF)
147Epidermal reinnervation after intracutaneous axotomy in man
Journal of Comparative Neurology, 2003, 457, 24-36
2.093Citations (PDF)
148FK506 is neuroprotective in a model of antiretroviral toxic neuropathy
Annals of Neurology, 2003, 53, 57-64
6.677Citations (PDF)
149Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons
Annals of Neurology, 2003, 54, 287-296
6.6180Citations (PDF)
150Nucleoside analogues and neuropathy in the era of HAART
Journal of Clinical Virology, 2003, 26, 195-207
3.081Citations (PDF)
151New Insights Into Diabetic Polyneuropathy
JAMA - Journal of the American Medical Association, 2003, 290, 1371
16.5117Citations (PDF)
152Acute Meningoencephalitis in Chronic Human Immunodeficiency Virus (HIV) Infection: Putative Central Nervous System Escape of HIV Replication
Clinical Infectious Diseases, 2003, 37, 1107-1111
5.250Citations (PDF)
153Stroke and HIV Infection
Stroke, 2003, 34,
5.95Citations (PDF)
154Recent developments in the HIV neuropathies
Current Opinion in Neurology, 2003, 16, 403-409
3.847Citations (PDF)
155Lamotrigine for HIV-associated painful sensory neuropathies
Neurology, 2003, 60, 1508-1514
1.0252Citations (PDF)
156Recent developments in the HIV neuropathies
Current Opinion in Neurology, 2003, 16, 403-409
3.849Citations (PDF)
157Human Immunodeficiency Virus-Associated Dementia: An Evolving Disease
Journal of NeuroVirology, 2003, 9, 205-221
1.624Citations (PDF)
158Incidence of and risk factors for HIV-associated distal sensory polyneuropathy
Neurology, 2002, 58, 1764-1768
1.0213Citations (PDF)
159Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels
Aids, 2002, 16, 407-412
2.582Citations (PDF)
160A randomized clinical trial of CPI-1189 for HIV-associated cognitive–motor impairment
Neurology, 2002, 59, 1568-1573
1.078Citations (PDF)
161Quantitative MR Spectroscopic Imaging of Brain Lesions in Patients with AIDS
Academic Radiology, 2002, 9, 398-409
2.743Citations (PDF)
162Skin Biopsy as a Tool to Assess Distal Small Fiber Innervation in Diabetic Neuropathy
Diabetes Technology and Therapeutics, 2001, 3, 23-28
4.699Citations (PDF)
163Identification by mRNA Differential Display of Two Up-regulated Genes as Candidate Mediators of AIDS Dementia
Molecular Medicine, 2001, 7, 193-199
5.62Citations (PDF)
164Assessment of cutaneous innervation by skin biopsies
Current Opinion in Neurology, 2001, 14, 655-659
3.867Citations (PDF)
165HIV in the brain
Neurology, 2001, 57, 1396-1401
1.048Citations (PDF)
166HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease
Journal of the Peripheral Nervous System, 2001, 6, 21-27
3.4241Citations (PDF)
167Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia
Annals of Neurology, 2001, 49, 745-752
6.6155Citations (PDF)
168Increased frequency of the tumor necrosis factor-?-308 a allele in adults with human immunodeficiency virus dementia
Annals of Neurology, 2001, 50, 157-162
6.689Citations (PDF)
169HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity
Journal of NeuroVirology, 2001, 7, 235-249
1.650Citations (PDF)
170HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir
Aids, 2001, 15, 747-751
2.548Citations (PDF)
171Subclinical sensory neuropathy in late-onset restless legs syndrome
Neurology, 2000, 55, 1115-1121
1.0254Citations (PDF)
172A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy
Neurology, 2000, 54, 2115-2119
1.0237Citations (PDF)
173Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea
Aids, 2000, 14, 273-278
2.5171Citations (PDF)
174Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration
Journal of Neuroimmunology, 2000, 109, 221-227
2.341Citations (PDF)
175A Pilot Study Evaluating Ceftriaxone and Penicillin G as Treatment Agents for Neurosyphilis in Human Immunodeficiency Virus-Infected Individuals
Clinical Infectious Diseases, 2000, 30, 540-544
5.2189Citations (PDF)
176Cytotoxicity by Matrix Metalloprotease-1 in Organotypic Spinal Cord and Dissociated Neuronal Cultures
Experimental Neurology, 2000, 163, 324-330
4.076Citations (PDF)
177Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy
Annual Review of Immunology, 2000, 18, 665-708
29.4509Citations (PDF)
178Rate and Severity of HIV-Associated Dementia (HAD): Correlations with Gp41 and iNOS
Molecular Medicine, 1999, 5, 98-109
5.689Citations (PDF)
179Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy
Neurology, 1999, 52, 607-607
1.0300Citations (PDF)
180Human Immunodeficiency Virus-Associated Dementia
Seminars in Neurology, 1999, 19, 129-150
1.7140Citations (PDF)
181Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies
Neurology, 1999, 53, 1634-1634
1.0270Citations (PDF)
182Randomized trial of the platelet-activating factor antagonist lexipafant in HIV–associated cognitive impairment
Neurology, 1999, 53, 391-391
1.078Citations (PDF)
183A Decision Guideline for Emergency Department Utilization of Noncontrast Head Computed Tomography in HIV‐infected Patients
Academic Emergency Medicine, 1999, 6, 1010-1019
1.723Citations (PDF)
184Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia
Annals of Neurology, 1999, 46, 391-398
6.6203Citations (PDF)
185HIV-associated primary CNS lymorbidity and utility of brain biopsy
Journal of the Neurological Sciences, 1999, 163, 32-38
2.176Citations (PDF)
186Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy
Journal of the Neurological Sciences, 1999, 164, 172-178
2.1176Citations (PDF)
187Quantitative analysis of epidermal innervation in Fabry disease
Neurology, 1999, 52, 1249-1249
1.0144Citations (PDF)
188Small‐fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases
Annals of Neurology, 1998, 44, 47-59
6.6332Citations (PDF)
189?-Chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia
Annals of Neurology, 1998, 44, 831-835
6.6343Citations (PDF)
190Remission after 13-cis retinoic acid in thrombotic thrombocytopenic purpura
Lancet, The, 1998, 352, 454-455
62.125Citations (PDF)
191Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-Interferon: an observational study
Journal of NeuroVirology, 1998, 4, 324-332
1.679Citations (PDF)
192Failure of Cytarabine in Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection
New England Journal of Medicine, 1998, 338, 1345-1351
34.5358Citations (PDF)
193Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity
Journal of NeuroVirology, 1998, 4, 387-393
1.652Citations (PDF)
194Sustained Cognitive Decline in HIV Infection: Relationship to CD4+ Cell Count, Plasma Viremia and p24 Antigenemia
Journal of NeuroVirology, 1998, 4, 95-99
1.616Citations (PDF)
195Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy
Journal of Neurology, Neurosurgery and Psychiatry, 1998, 65, 762-766
6.397Citations (PDF)
196Variable progression of HIV‐associated dementia
Neurology, 1998, 50, 1814-1820
1.0152Citations (PDF)
197A phase I/II trial of nimodipine for HIV-related neurologic complications
Neurology, 1998, 51, 221-228
1.0113Citations (PDF)
198Epidermal Nerve Fiber Density
Archives of Neurology, 1998, 55, 1513
6.8547Citations (PDF)
199Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
Proceedings of the National Academy of Sciences of the United States of America, 1998, 95, 3117-3121
7.5571Citations (PDF)
200Prospects for therapy of HIV-associated neurologic diseases
Journal of NeuroVirology, 1997, 3, 89-101
1.639Citations (PDF)
201HIV Infection and Cognition in Intravenous Drug Users
Neurology, 1997, 48, 223-230
1.061Citations (PDF)
202Intraepidermal nerve fiber density in patients with painful sensory neuropathy
Neurology, 1997, 48, 708-711
1.0292Citations (PDF)
203Myelopathy Among Brazilians Coinfected with Human T-cell Lymphotropic Virus Type I and HIV
Neurology, 1997, 48, 13-18
1.054Citations (PDF)
204NeuroAIDS: Diagnosis and Management
Hospital Practice (1995), 1997, 32, 73-97
1.08Citations (PDF)
205Sensory and Motor Denervation Influence Epidermal Thickness in Rat Foot Glabrous Skin
Experimental Neurology, 1997, 147, 452-462
4.060Citations (PDF)
206The neurology complications of HIV infection
Electroencephalography and Clinical Neurophysiology, 1997, 102, P3
2.40Citations (PDF)
207Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry
Journal of Neuroimmunology, 1997, 74, 1-8
2.3165Citations (PDF)
208Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain
Annals of Neurology, 1997, 42, 689-698
6.6408Citations (PDF)
209NEUROEPIDEMIOLOGY OF HIV INFECTION
Neurologic Clinics, 1996, 14, 359-382
2.620Citations (PDF)
210LABORATORY TESTING IN PERIPHERAL NERVE DISEASE
Neurologic Clinics, 1996, 14, 119-133
2.619Citations (PDF)
2115.4 HIV‐induced neurological disease
Medical Journal of Australia, 1996, 164, 414-417
1.71Citations (PDF)
212Stereological Analysis of Cerebral Atrophy in Human Immunodeficiency Virus-associated Dementia
Journal of Neuropathology and Experimental Neurology, 1996, 55, 1032-1037
1.829Citations (PDF)
213Epidermal denervation and its effects on keratinocytes and Langerhans cells
Journal of Neurocytology, 1996, 25, 513-524
2.1132Citations (PDF)
214An unbiased method for estimation of total epidermal nerve fibre length
Journal of Neurocytology, 1996, 25, 637-644
2.162Citations (PDF)
215Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome
Annals of Neurology, 1996, 39, 392-395
6.6128Citations (PDF)
216Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry
Annals of Neurology, 1996, 39, 705-711
6.6422Citations (PDF)
217HIV dementia: 10 years on
Journal of NeuroVirology, 1996, 2, 8-8
1.61Citations (PDF)
218Low-dose zalcitabine-related toxic neuropathy
Neurology, 1996, 46, 999-1003
1.084Citations (PDF)
219A Quantitative MRI Study of the Basal Ganglia in Depression in HIV Seropositive Men
Journal of Neuro-AIDS, 1996, 1, 29-41
0.06Citations (PDF)
220Adequately Treated Remote Syphilis Does Not Augment CNS HIV-1 Expression
Journal of Neuro-AIDS, 1996, 1, 87-96
0.00Citations (PDF)
221Stereological Analysis of Cerebral Atrophy in Human Immunodeficiency Virus-associated Dementia
Journal of Neuropathology and Experimental Neurology, 1996, 55, 1032-1037
1.80Citations (PDF)
222Unifying Hypothesis for the Pathogenesis of HIV-Associated Dementia Complex, Vacuolar Myelopathy, and Sensory Neuropathy
Journal of Acquired Immune Deficiency Syndromes, 1995, 9, 379???388
0.3115Citations (PDF)
223Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia
Annals of Neurology, 1995, 38, 755-762
6.6674Citations (PDF)
224Cutaneous innervation in sensory neuropathies
Neurology, 1995, 45, 1848-1855
1.0477Citations (PDF)
225HIV Dementia Scale: A Rapid Screening Test
Journal of Acquired Immune Deficiency Syndromes, 1995, 8, 273-278
0.3318Citations (PDF)
226An Epidemiologic Analysis of Mycobacterium avium Complex Disease in Homosexual Men Infected with Human Immunodeficiency Virus Type 1
Clinical Infectious Diseases, 1995, 20, 1250-1258
5.239Citations (PDF)
227Cognitive performance after progression to AIDS
Neurology, 1995, 45, 267-275
1.078Citations (PDF)
228A Potential Role for Interferon-α in the Pathogenesis of HIV-Associated Dementia
Brain, Behavior, and Immunity, 1995, 9, 366-377
4.5109Citations (PDF)
229Normative Data for a Brief Neuropsychologic Test Battery in a Cohort of Injecting Drug Users
Substance Use and Misuse, 1995, 30, 823-841
1.128Citations (PDF)
230Clinicopathologic correlations of HIV‐1‐associated vacuolar myelopathy
Neurology, 1994, 44, 2159-2159
1.0135Citations (PDF)
231Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia
Acta Neuropathologica, 1994, 88, 538-544
9.187Citations (PDF)
232Elevated central nervous system prostaglandins in human immunodeficiency virus?associated dementia
Annals of Neurology, 1994, 35, 592-597
6.6225Citations (PDF)
233Cytokine dysregulation in HIV-associated neurological disease
Advances in Neuroimmunology, 1994, 4, 199-206
1.784Citations (PDF)
234Altered cortical blood flow in HIV-seropositive individuals with and without dementia
Aids, 1994, 8, 495-500
2.527Citations (PDF)
235Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences
Journal of Virology, 1994, 68, 4643-4649
3.6271Citations (PDF)
236Temporal trends in the incidence of HTV‐1‐related neurologic diseases
Neurology, 1994, 44, 1892-1892
1.0286Citations (PDF)
237Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS)
Neurology, 1994, 44, 507-507
1.0147Citations (PDF)
238Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dememtia
Annals of Neurology, 1993, 33, 576-582
6.6448Citations (PDF)
239Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier
Annals of Neurology, 1993, 34, 339-350
6.6354Citations (PDF)
240Radiographic Imaging of Sinusitis in HIV Infection
Otolaryngology - Head and Neck Surgery, 1993, 108, 36-43
2.311Citations (PDF)
241Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS
Neurology, 1993, 43, 493-493
1.077Citations (PDF)
242Reduced basal ganglia volume in HIV‐1‐associated dementia
Neurology, 1993, 43, 2099-2099
1.0332Citations (PDF)
243Clinical‐neuropathologic correlation in HIV‐associated dementia
Neurology, 1993, 43, 2230-2230
1.0323Citations (PDF)
244Dementia in AIDS patients
Neurology, 1993, 43, 2245-2245
1.0632Citations (PDF)
245Cytokine expression of macrophages in HIV‐1‐associated vacuolar myelopathy
Neurology, 1993, 43, 1002-1002
1.085Citations (PDF)
246HIV‐1 infection and intravenous drug use
Neurology, 1992, 42, 1924-1924
1.060Citations (PDF)
247Cerebrospinal fluid (β2-microglobulin in patients with AIDS dementia complex
Aids, 1992, 6, 461-466
2.596Citations (PDF)
248Effect of Chronic Substance Abuse on the Neuropsychological Performance of Intravenous Drug Users with a High Prevalence of HIV-1 Seropositivity
American Journal of Epidemiology, 1992, 136, 1338-1348
3.344Citations (PDF)
249Cytokine expression in the brain during the acquired immunodeficiency syndrome
Annals of Neurology, 1992, 31, 349-360
6.6605Citations (PDF)
250Patterns of cerebral atrophy in HIV–1–infected individuals
Neurology, 1992, 42, 2125-2125
1.0158Citations (PDF)
251Asymptomatic HIV infection does not cause EEG abnormalities
Neurology, 1992, 42, 1214-1214
1.037Citations (PDF)
252The diagnostic utility of elevation in cerebrospinal fluid β 2 ‐microglobulin in HIV‐1 dementia
Neurology, 1992, 42, 1707-1707
1.0125Citations (PDF)
253Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
Lancet, The, 1991, 338, 969-973
62.1522Citations (PDF)
254HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology
Brain Pathology, 1991, 1, 143-152
5.0330Citations (PDF)
255Stereotactic Brain Biopsy in the Diagnosis of Malignant Lymphoma
American Journal of Clinical Pathology, 1991, 95, 878-883
0.735Citations (PDF)
256Normative Data for a Brief Neuropsychological Screening Battery
Perceptual and Motor Skills, 1991, 73, 539-550
1.5121Citations (PDF)
257Metacognition in HIV-1 seropositive asymptomatic individuals: Self-ratings versus objective neuropsychological performance
Neuropsychology, Development and Cognition Section A: Journal of Clinical and Experimental Neuropsychology, 1991, 13, 812-819
1.690Citations (PDF)
258Neopterin and interferon‐gamma in serum and cerebrospinal fluid of patients with HIV‐associated neurologic disease
Neurology, 1991, 41, 69-69
1.0137Citations (PDF)
259HIV‐1 infection and nervous system abnormalities among a cohort of intravenous drug users
Neurology, 1991, 41, 1905-1905
1.040Citations (PDF)
260NORMATIVE DATA FOR A BRIEF NEUROPSYCHOLOGICAL SCREENING BATTERY
Perceptual and Motor Skills, 1991, 73, 539
1.528Citations (PDF)
261Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection
Annals of Neurology, 1990, 28, 556-560
6.6176Citations (PDF)
262Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease
Journal of Neuroimmunology, 1990, 28, 97-109
2.335Citations (PDF)
263Quantitative analysis of endoneurial T-cells in human sural nerve biopsies
Journal of Neuroimmunology, 1990, 26, 113-118
2.386Citations (PDF)
264Neuropsychological performance in HIV‐1‐infected homosexual men
Neurology, 1990, 40, 197-197
1.0313Citations (PDF)
265HIV‐1 infection
Neurology, 1990, 40, 204-204
1.0176Citations (PDF)
266Intrathecal synthesis of anti‐HIV IgG
Neurology, 1990, 40, 816-816
1.021Citations (PDF)
267Steroid‐responsive myeloneuropathy in a man dually infected with HIV‐1 and HTLV‐I
Neurology, 1990, 40, 938-938
1.027Citations (PDF)
268Identification of mononuclear cells in CSF of patients with HIV infection
Neurology, 1989, 39, 66-66
1.038Citations (PDF)
269Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: Results from the multicenter AIDS cohort study
Annals of Neurology, 1989, 26, 601-611
6.6282Citations (PDF)
270Neuropathological changes in early HIV-1 dementia
Annals of Neurology, 1989, 26, 681-684
6.671Citations (PDF)
271The Guillain-Barré syndrome and human immunodeficiency virus
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1989, 83, 575
1.31Citations (PDF)
272Human immunodeficiency virus (HIV) infection and the nervous system
Neurology, 1989, 39, 119-119
1.078Citations (PDF)
273Nifedipine in the prophylaxis of classic migraine
Neurology, 1989, 39, 284-284
1.036Citations (PDF)
274DIFFERENT PATTERNS OF PNS DEMYELINATION OCCUR IN HIV INFECTION
Journal of Neuropathology and Experimental Neurology, 1989, 48, 381
1.80Citations (PDF)
275Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings
Annals of Neurology, 1988, 23, S34-S37
6.6161Citations (PDF)
276Flow cytometric quantitation of T cell phenotypes in cerebrospinal fluid and peripheral blood of homosexual men with and without antibodies to human immunodeficiency virus, type I
Journal of Neuroimmunology, 1988, 20, 73-81
2.325Citations (PDF)
277Gracile tract degeneration in patients with sensory neuropathy and AIDS
Neurology, 1988, 38, 265-265
1.0109Citations (PDF)
278Predominantly sensory neuropathy in patients with AIDS and AIDS‐related complex
Neurology, 1988, 38, 794-794
1.0278Citations (PDF)
279Neurologic Manifestations of AIDS
Medicine (United States), 1987, 66, 407-437
1.2408Citations (PDF)
280Central Nervous System Complications of Human Immunodeficiency Virus
The American Journal of EEG Technology, 1987, 27, 33-49
0.13Citations (PDF)
281Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection
Annals of Neurology, 1987, 21, 32-40
6.6379Citations (PDF)
282AIDS and the brain
Trends in Neurosciences, 1986, 9, 91-94
9.843Citations (PDF)
283Another differential for mutism
Annals of Neurology, 1986, 20, 273-274
6.61Citations (PDF)
284Univariate and Multivariate Analyses of the Mental Status Examination
Journal of the American Geriatrics Society, 1985, 33, 483-488
2.9128Citations (PDF)
285Recognition of Dementia Among Medical Patients
Archives of Internal Medicine, 1984, 144, 73
8.142Citations (PDF)
286MALARIA CONTROL IN BORNEO
Lancet, The, 1953, 262, 655-656
62.14Citations (PDF)